PMC:7417114 / 1027-1320 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":28,"end":36},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"anti-inflammatory activity, cytokine suppression, or antifibrotic activity. Certain agents are projected to be dual-purpose drugs in terms of antiviral activity and alleviation of disease symptoms, however drug combination is also an option for inhibitors with optimal pharmacokinetic properti"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T6","span":{"begin":18,"end":26},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T7","span":{"begin":66,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T8","span":{"begin":152,"end":160},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"anti-inflammatory activity, cytokine suppression, or antifibrotic activity. Certain agents are projected to be dual-purpose drugs in terms of antiviral activity and alleviation of disease symptoms, however drug combination is also an option for inhibitors with optimal pharmacokinetic properti"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":124,"end":129},"obj":"Chemical"},{"id":"T7","span":{"begin":142,"end":151},"obj":"Chemical"},{"id":"T8","span":{"begin":206,"end":210},"obj":"Chemical"},{"id":"T9","span":{"begin":245,"end":255},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"anti-inflammatory activity, cytokine suppression, or antifibrotic activity. Certain agents are projected to be dual-purpose drugs in terms of antiviral activity and alleviation of disease symptoms, however drug combination is also an option for inhibitors with optimal pharmacokinetic properti"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T19","span":{"begin":84,"end":90},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T20","span":{"begin":124,"end":129},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T21","span":{"begin":206,"end":210},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T22","span":{"begin":245,"end":255},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T23","span":{"begin":269,"end":284},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T43246","span":{"begin":84,"end":90},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T77831","span":{"begin":124,"end":129},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T1907","span":{"begin":206,"end":210},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T22154","span":{"begin":245,"end":255},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T69545","span":{"begin":269,"end":284},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"anti-inflammatory activity, cytokine suppression, or antifibrotic activity. Certain agents are projected to be dual-purpose drugs in terms of antiviral activity and alleviation of disease symptoms, however drug combination is also an option for inhibitors with optimal pharmacokinetic properti"}